Shots:

• The FDA’s approval is based on CLARITY study assessing Cerene in 242 patients with excessive menstrual bleeding
• The CLARITY study results: @12mos. reduction in menstrual bleeding; m-pain score (0-2/10); no general anesthesia required; reduction in post-operative pain & intrauterine adhesions (81% and 79%); well tolerated without anesthesia
• The Cerene is a cryotherapy device that delivers cryotherapy to freeze the lining of uterus for future reduction in mensural bleeding and is targeted for endometrial cryoablation in premenopausal women

Click here to read full press release/ article | Ref: Channel Medsystems | Image: Data Research